Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Do You Know Where Your Instruments Are? How Surgical Instrument Marking Can Improve Your Perioperative feat. Bill Camargo and Jennifer Bingaman

Ahead of any surgical procedure or operation is the preparation of surgical instruments. In the latest episode of the podcast “ConCensis,” host Tyler Kern discussed the ins and outs of how Censis utilizes its software to facilitate the use of surgical instruments throughout the full perioperative loop by putting marks on each individual instrument. He…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Censis on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Ahead of any surgical procedure or operation is the preparation of surgical instruments. In the latest episode of the podcast “ConCensis,” host Tyler Kern discussed the ins and outs of how Censis utilizes its software to facilitate the use of surgical instruments throughout the full perioperative loop by putting marks on each individual instrument. He spoke with Bill Camargo, Manager of Marking Services, and Jennifer Bingaman, Director of Business Services, on how Censis gets it right.

According to Camargo, there are three main types of surgical instrument markings commonly used – laser, electrochemical, and mechanical. Laser is the most popular, however, there are instances where one or more may be utilized together. For laser marking a significant amount of space is needed between the lens and instrument of marking, so that’s when electrochemical and mechanical marking come into play.

“With some instrument configurations, it’s very difficult, if not impossible, to mark it with a laser, that’s where electrochemical comes into play,” said Camargo. He went on to note that mechanical markings come through with a solution if the former two aren’t the best options. The downside to mechanical markings is their lack of permanence.

Marking allows the perioperative to be as smooth and clear as possible. It also makes the job of operating room (OR) staff members much smoother, particularly in critical times. Facilities choose to mark instruments to maintain efficient organization and tracking, according to Bingaman.

“There’s usually two main reasons why people choose to mark instruments, the biggest being that when you’re assembling a tray in sterile processing and you’re able to scan each instrument to that set, it helps ensure that you have a complete set to the OR, so that OR staff aren’t spending their time looking for missing instruments,” said Bingaman.

Surgical instrument marking also makes identifying and pinpointing the source of any issue that might arise during a procedure. While each surgical instrument tray is unique, when surgical instruments have markings, it clarifies a particular instrument giving you a deeper level of tracking information.

“If God forbid there’s an infection control issue, then if you have instruments marked and you’re scanning at instrument level, then you know exactly what instruments were used on that patient, rather than just knowing this tray was used on this patient. You actually get down to the instrument level,” said Bingaman.

Censis’s CensiTrac software adds another element that improves surgical instrument marking and tracking. Bingaman compared the tracking method to manufacturing barcodes. Similar to how barcodes identify what products were just scanned in a grocery store for example, entering surgical instrument data into the CensiTrac system will help it know what instrument is being used.

Interested in learning more about Censis Technologies’ surgical asset management platform? Visit Censis.com.

Censis

Part of this channel

Censis

Surgical instrument management software for over 1,300 U.S. hospitals.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512